These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

823 related items for PubMed ID: 11095740

  • 1. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors.
    Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, Schroeder L, Aderem A.
    Proc Natl Acad Sci U S A; 2000 Dec 05; 97(25):13766-71. PubMed ID: 11095740
    [Abstract] [Full Text] [Related]

  • 2. Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors.
    Nishiya T, DeFranco AL.
    J Biol Chem; 2004 Apr 30; 279(18):19008-17. PubMed ID: 14976215
    [Abstract] [Full Text] [Related]

  • 3. Novel engagement of CD14 and multiple toll-like receptors by group B streptococci.
    Henneke P, Takeuchi O, van Strijp JA, Guttormsen HK, Smith JA, Schromm AB, Espevik TA, Akira S, Nizet V, Kasper DL, Golenbock DT.
    J Immunol; 2001 Dec 15; 167(12):7069-76. PubMed ID: 11739528
    [Abstract] [Full Text] [Related]

  • 4. Simultaneous blocking of human Toll-like receptors 2 and 4 suppresses myeloid dendritic cell activation induced by Mycobacterium bovis bacillus Calmette-Guérin peptidoglycan.
    Uehori J, Matsumoto M, Tsuji S, Akazawa T, Takeuchi O, Akira S, Kawata T, Azuma I, Toyoshima K, Seya T.
    Infect Immun; 2003 Aug 15; 71(8):4238-49. PubMed ID: 12874299
    [Abstract] [Full Text] [Related]

  • 5. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins.
    Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, Dong Z, Modlin RL, Akira S.
    J Immunol; 2002 Jul 01; 169(1):10-4. PubMed ID: 12077222
    [Abstract] [Full Text] [Related]

  • 6. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2.
    Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D.
    J Immunol; 1999 Jul 01; 163(1):1-5. PubMed ID: 10384090
    [Abstract] [Full Text] [Related]

  • 7. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products.
    Lien E, Sellati TJ, Yoshimura A, Flo TH, Rawadi G, Finberg RW, Carroll JD, Espevik T, Ingalls RR, Radolf JD, Golenbock DT.
    J Biol Chem; 1999 Nov 19; 274(47):33419-25. PubMed ID: 10559223
    [Abstract] [Full Text] [Related]

  • 8. Toll-like receptors as sensors of pathogens.
    Hallman M, Rämet M, Ezekowitz RA.
    Pediatr Res; 2001 Sep 19; 50(3):315-21. PubMed ID: 11518816
    [Abstract] [Full Text] [Related]

  • 9. Surface-expressed TLR6 participates in the recognition of diacylated lipopeptide and peptidoglycan in human cells.
    Nakao Y, Funami K, Kikkawa S, Taniguchi M, Nishiguchi M, Fukumori Y, Seya T, Matsumoto M.
    J Immunol; 2005 Feb 01; 174(3):1566-73. PubMed ID: 15661917
    [Abstract] [Full Text] [Related]

  • 10. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens.
    Underhill DM, Ozinsky A, Hajjar AM, Stevens A, Wilson CB, Bassetti M, Aderem A.
    Nature; 1999 Oct 21; 401(6755):811-5. PubMed ID: 10548109
    [Abstract] [Full Text] [Related]

  • 11. Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1.
    Lee JY, Zhao L, Youn HS, Weatherill AR, Tapping R, Feng L, Lee WH, Fitzgerald KA, Hwang DH.
    J Biol Chem; 2004 Apr 23; 279(17):16971-9. PubMed ID: 14966134
    [Abstract] [Full Text] [Related]

  • 12. Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells.
    McCurdy JD, Olynych TJ, Maher LH, Marshall JS.
    J Immunol; 2003 Feb 15; 170(4):1625-9. PubMed ID: 12574323
    [Abstract] [Full Text] [Related]

  • 13. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection.
    Malley R, Henneke P, Morse SC, Cieslewicz MJ, Lipsitch M, Thompson CM, Kurt-Jones E, Paton JC, Wessels MR, Golenbock DT.
    Proc Natl Acad Sci U S A; 2003 Feb 18; 100(4):1966-71. PubMed ID: 12569171
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Macrophages exposed continuously to lipopolysaccharide and other agonists that act via toll-like receptors exhibit a sustained and additive activation state.
    Hume DA, Underhill DM, Sweet MJ, Ozinsky AO, Liew FY, Aderem A.
    BMC Immunol; 2001 Feb 18; 2():11. PubMed ID: 11686851
    [Abstract] [Full Text] [Related]

  • 18. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut.
    Melmed G, Thomas LS, Lee N, Tesfay SY, Lukasek K, Michelsen KS, Zhou Y, Hu B, Arditi M, Abreu MT.
    J Immunol; 2003 Feb 01; 170(3):1406-15. PubMed ID: 12538701
    [Abstract] [Full Text] [Related]

  • 19. Recognition of lipopeptides by Toll-like receptors.
    Takeda K, Takeuchi O, Akira S.
    J Endotoxin Res; 2002 Feb 01; 8(6):459-63. PubMed ID: 12697090
    [Abstract] [Full Text] [Related]

  • 20. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
    Horng T, Barton GM, Flavell RA, Medzhitov R.
    Nature; 2002 Nov 21; 420(6913):329-33. PubMed ID: 12447442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.